文献速递外周动脉疾病

肢体缺血治疗指征与结局的种族差异

Racial Disparities in Treatment Indications and Outcomes for Limb Ischemia.
PubMed 文献 · Ann Vasc Surg · 2023-04-30

基于血管质量倡议(VQI)数据库,纳入2016至2021年接受下肢旁路术(LEB,17455例)或外周血管介入(PVI,87475例)的患者,比较黑人与非西班牙裔白人(NHW)的临床表现与结局。黑人患者更年轻、合并症更多、更常表现为慢性肢体威胁性缺血(CLTI)且更紧急,1年主要不良肢体事件(MALE)风险更高:LEB校正风险比(aHR)1.15(95%CI [1.05-1.26],P=0.003),PVI aHR 1.18(95%CI [1.12-1.24],P<0.001)。

要点

  • 黑人患者接受LEB或PVI时更年轻,糖尿病、高血压、终末期肾病(ESRD)及既往截肢比例更高。
  • 黑人患者更常以CLTI而非跛行就诊,且就诊时病情更紧急。
  • 黑人患者1年MALE风险更高:LEB aHR 1.15(95%CI [1.05-1.26],P=0.003),PVI aHR 1.18(95%CI [1.12-1.24],P<0.001)。

核心结论

  • 与非西班牙裔白人相比,黑人患者无论手术指征如何,均表现为更晚期的血管病变。
  • 黑人患者1年MALE风险显著更高,尽管2014年《平价医疗法案》(ACA)改善了医疗可及性,但观察结果提示黑人患者结局仍显著更差,涉及多种变量需进一步研究。

研究设计与样本

  • 回顾性队列分析,查询VQI腹股沟下和PVI数据集,纳入2016年(ACA实施2年后)至2021年接受择期和紧急LEB或PVI的患者。
  • 排除紧急/急诊干预或动脉瘤患者;共纳入17455例LEB和87475例PVI。
  • 主要结局为1年无主要不良肢体事件(MALE,定义为任何血管再干预或踝上截肢)生存。

主要发现

  • 黑人患者较非西班牙裔白人更年轻,糖尿病、高血压、终末期肾病(ESRD)及既往截肢比例更高。
  • 黑人患者更常表现为CLTI而非跛行,且病情更紧急。
  • 术后大截肢率:LEB黑人1.8% vs 非西班牙裔白人0.8%(P<0.001);PVI黑人20.8% vs 非西班牙裔白人16.8%(P<0.001)。
  • 1年MALE:LEB黑人36.7% vs 非西班牙裔白人29.9%(P<0.001);PVI黑人31.0% vs 非西班牙裔白人21.7%(P<0.001)。
  • 校正混杂因素后,黑人1年MALE风险仍更高:LEB aHR 1.15(95%CI [1.05-1.26],P=0.003),PVI aHR 1.18(95%CI [1.12-1.24],P<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Studies suggest that the Affordable Care Act (ACA) of 2014 has improved access to vascular care and vascular outcomes among patients suffering from peripheral arterial disease (PAD). We sought to examine the racial disparities that exist in patients with PAD who have undergone lower extremity bypass (LEB) or a peripheral vascular intervention (PVI) using the Vascular Quality initiative (VQI) database. METHODS: The VQI infrainguinal and PVI datasets were queried for patients receiving elective and urgent LEB or PVI between 2016, 2 years after ACA implementation, and in 2021. Patients undergoing interventions urgently/emergently or for aneurysm were excluded. The primary outcome was major adverse limb event (MALE-defined as any vascular reintervention or above-ankle amputation) free survival at 1 year. Standard statistical methods were utilized as appropriate. RESULTS: A total of 17,455 LEB and 87,475 PVIs were included in this analysis. Black persons present at a younger age when compared to non-Hispanic White persons (NHW) and are more likely to have diabetes, hypertension, end-stage renal disease (ESRD), and higher rates of prior amputation. Black persons are more likely to present with chronic limb-threatening ischemia (CLTI) rather than claudication, and in a more urgent setting. Postoperative outcomes show higher rates of major amputations among racial minorities, specifically Black persons for both LEB (1.8% vs. 0.8% P < 0.001) and PVI (20.8% vs. 16.8% P < 0.001). Black persons are at higher risk of 1-year MALE for LEB (36.7% vs. 29.9% P < 0.001) and PVI (31.0% vs. 21.7%; P < 0.001). Even after adjusting for confounding variables, Black persons have a higher risk of 1-year MALE for LEB, with an adjusted hazard ratio (aHR) of 1.15 (95% CI [1.05-1.26], P = 0.003) and PVI (aHR 1.18 95% CI [1.12-1.24], P < 0.001). Other major determinates of 1-year MALE on multivariate Cox regression included CLTI (LEB aHR 1.57 95% CI [1.43-1.72], P < 0.001; PVI aHR 2.29 95% CI [2.20-2.39], P < 0.001) and history of prior amputation (LEB aHR 1.35 95% CI [1.17-1.56], P < 0.001; PVI aHR 1.5 95% CI [1.4-1.6], P < 0.001). CONCLUSIONS: Compared to NHW persons, Black persons present with more advanced vascular disease regardless of the operative indication. Black persons are also at significantly higher risk of 1-year MALE. Despite some advances in more accessible care through the ACA of 2014, our observations suggest that Black persons still have significantly worse outcomes due to variety of variables that need further investigation.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Semaan DB, Abdul-Malak OM, Avgerinos ED, et al. Racial Disparities in Treatment Indications and Outcomes for Limb Ischemia. Ann Vasc Surg. 2023. PMID: 37737257. doi:10.1016/j.avsg.2023.04.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。